It means that BPC-157 remains outside standard FDA-approved treatment pathways and should be used thoughtfully under physician guidance
injections are typically 1 mg every other day, or twice weekly
These openings are very small and normally heal up and become invisible after the treatment
In the laboratory, researchers study BPC-157 in cell-culture and preclinical models to investigate processes associated with tissue repair, fibroblast behavior, collagen organization, and angiogenesis-related signaling, including pathways linked to vascular endothelial growth factor (VEGF) and nitric-oxide systems
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Maintain proper storage consistently, and you eliminate a major variable from your dosing equation